Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Antibiotic Resistance in Urinary Tract Infections in College Students
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Olson, Ronald P.; Haith, Karen
- Language:
English
- Source:
Journal of American College Health. 2012 60(6):471-474.
- Physical Description:
PDF
- Publication Date:
2012
- Document Type:
Journal Articles
Reports - Research
- Additional Information
- Availability:
Routledge. Available from: Taylor & Francis, Ltd. 325 Chestnut Street Suite 800, Philadelphia, PA 19106. Tel: 800-354-1420; Fax: 215-625-2940; Web site: http://www.tandf.co.uk/journals
- Peer Reviewed:
Y
- Source:
4
- Education Level:
Higher Education
- Subject Terms:
- Accession Number:
10.1080/07448481.2012.681410
- ISSN:
0744-8481
- Abstract:
Objective: To determine resistance to antibiotics of "Escherichia coli" in uncomplicated urinary tract infections (uUTIs) in female college students. Participants: Symptomatic patients presenting to a student health service from September 2008 to December 2009. Methods: Clean catch midstream urine samples were tested for urinalysis (UA) and culture and sensitivity. Results: Of 168 students enrolled in the study, 138 had positive UA, and 94 of these grew greater than 100,000 colonies/mL of "E. coli". Ampicillin resistance was 31.9%, trimethoprim-sulfamethoxazole (TMP-SMX) resistance 16.0%, ciprofloxacin resistance 4.3%, amoxicillin/clavulanate resistance 3.2%, and nitrofurantoin resistance 1.1%. The sensitivity of UA was 95.4% and the positive predictive value was 87.0% (p [less than or equal to] 0.001). Specificity was 77.5% and negative predictive value 92.9%. Conclusions: In healthy college women with uUTI symptoms, TMP-SMX should not be universally used for empirical therapy, whereas use of ciprofloxacin, amoxicillin/clavulanate, and nitrofurantoin are appropriate.
- Abstract:
As Provided
- Number of References:
40
- Publication Date:
2013
- Accession Number:
EJ994451
No Comments.